Skip to content

Clinical trials

Withdrawn Uterine Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Neoplasms Status: Withdrawn Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20101
20121
20181
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center1
Dana-Farber Cancer Institute1
M.D. Anderson Cancer Center1
Memorial Sloan Kettering Cancer Center1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
Sir Mortimer B. Davis - Jewish General Hospital1
University of New Mexico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Neoplasms8
Endometrial Neoplasms4
Lung Neoplasms2
Neoplasms2
Uterine Cervical Neoplasms2
Bile Duct Neoplasms1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Cystadenocarcinoma, Serous1
Fallopian Tube Neoplasms1

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.